THE COX MAZE PROCEDURE FOR STAND ALONE ATRIAL FIBRILLATION  by Ad, Niv et al.
Arrhythmias
E586
JACC March 27, 2012
Volume 59, Issue 13
THE COX MAZE PROCEDURE FOR STAND ALONE ATRIAL FIBRILLATION
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Monday, March 26, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Arrhythmias: AF/SVT - Catheter and Surgical Ablation of Atrial Fibrillation
Abstract Category: 16. Arrhythmias: AF/SVT
Presentation Number: 1233-1
Authors: Niv Ad, Linda Henry, Sharon Hunt, Lisa Martin, Lori Stone, Inova Heart and Vascular Institute, Falls Church, VA, USA
Background: Data based on several national registries suggest a significant increase in non-pharmacological treatments for atrial fibrillation (AF). 
The majority of procedures reported are catheter based not surgical based possibly related to the perception that surgical ablation to include the 
Cox Maze procedure have a relatively lower yield and significant morbidity. We studied our perioperative outcomes and long term results of the stand 
alone Cox-Maze III/IV.
Methods: All patients were followed prospectively through an AF registry. A HRQL (SF-12) survey and a symptom and severity tool (Atrial Fibrillation 
Symptom Frequency and Severity Checklist) to evaluate AF burden were completed prior to surgery and 6 months post surgery. Rhythm verification 
was EKG/Holter. Recurrence of AF was any monitored atrial arrhythmia > 30 seconds as per the Heart Rhythm Society.
Results: Since 2005, 624 concomitant and stand alone surgical ablation procedures were performed- 171 patients were referred for and 123 
patients had a stand alone Cox-Maze III/IV procedure. The average age was 56 years ( 22-81), 86% males, 15% had previous stroke, 80% had 
long term persistent AF, 44 % had previous catheter ablations (range of 1-5 ablations) and mean LA size of 4.8 cm (2.6-9.9 cm). The average 
length of stay was 5.3d + 3.4. The perioperative outcomes were: 0.8% operative mortality (30 days) 0.8%, no CVA/TIA, 0.8% renal failure rate, 
1.6% reoperation for bleeding and 1 readmission at 30 days. The return to sinus rhythm at 12 and 24 months on and off antiarrhythmic drugs was 
94%,94%, 86%,81% respectively. At 24 months, 90% of the patients were off warfarin and only 1 embolic stroke mean follow-up of 39.3 months 
(1-79 months). Kaplan Meir analysis survival was 97% at 5 years. HRQL improved significantly (p=0.0001) surpassing age group norms. AF checklist 
scores (tiredness, heart flutter/racing, lightheadedness and weakness) decreased significantly (P=0.0001).
Conclusions: The Cox Maze procedure can be performed with very low morbidity. The long term success rate is promising with very high success 
rate off antiarrhythmic drugs and blood thinners. Quality of life improved significantly with a very low rate of thromboembolic events.
